Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Atezolizumab|PROCEDURE: Stereotactic radiosurgery (SRS)
Sponsor: Dana-Farber Cancer Institute
Collaborators: Genentech, Inc.